These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26849157)

  • 1. Decentralizing Access to Antiretroviral Therapy for Children Living with HIV in Swaziland.
    Auld AF; Nuwagaba-Biribonwoha H; Azih C; Kamiru H; Baughman AL; Agolory S; Abrams E; Ellerbrock TV; Okello V; Bicego G; Ehrenkranz P
    Pediatr Infect Dis J; 2016 Aug; 35(8):886-93. PubMed ID: 26849157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and Operational Research: Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services.
    Auld AF; Kamiru H; Azih C; Baughman AL; Nuwagaba-Biribonwoha H; Ehrenkranz P; Agolory S; Sahabo R; Ellerbrock TV; Okello V; Bicego G
    J Acquir Immune Defic Syndr; 2015 May; 69(1):e1-12. PubMed ID: 25942465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
    Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
    Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.
    Auld AF; Alfredo C; Macassa E; Jobarteh K; Shiraishi RW; Rivadeneira ED; Houston J; Spira TJ; Ellerbrock TV; Vaz P
    Pediatr Infect Dis J; 2015 Aug; 34(8):e191-9. PubMed ID: 25955836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High retention among HIV-infected children in Rwanda during scale-up and decentralization of HIV care and treatment programs, 2004 to 2010.
    Tene G; Lahuerta M; Teasdale C; Mugisha V; Kayonde L; Muhayimpundu R; Nyemazi JP; Vandebriel G; Nsanzimana S; Sahabo R; Twyman P; Abrams EJ
    Pediatr Infect Dis J; 2013 Aug; 32(8):e341-7. PubMed ID: 23407098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of loss to follow-up and its predictors among HIV-infected under-five children after initiation of antiretroviral therapy in West Amhara Comprehensive Specialized Referral Hospitals, Northwest Ethiopia: a multicenter retrospective follow-up study.
    Alemu GG; Tesfie TK; Abuhay HW; Mengistu B; Awoke G; Kefale GT; Beyene MM; Nibret M
    BMC Pediatr; 2024 Sep; 24(1):615. PubMed ID: 39342164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study.
    Hibstie YT; Kibret GD; Talie A; Temesgen B; Melkamu MW; Alebel A
    PLoS One; 2020; 15(9):e0239013. PubMed ID: 32931502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART.
    Nuwagaba-Biribonwoha H; Kiragga AN; Yiannoutsos CT; Musick BS; Wools-Kaloustian KK; Ayaya S; Wolf H; Lugina E; Ssali J; Abrams EJ; Elul B;
    J Int AIDS Soc; 2018 Sep; 21(9):e25178. PubMed ID: 30225908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Jan; 19(1):115. PubMed ID: 30691416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss to follow-up and its predictors among children living with HIV on antiretroviral therapy, southern Oromia, Ethiopia: a 5-year retrospective cohort study.
    Bankere AW; Daba SG; Ami B; Gedefa LK; Lencha B
    BMJ Open; 2024 Jul; 14(7):e078370. PubMed ID: 39089715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival among HIV-positive children on ART in Swaziland.
    Shabangu P; Beke A; Manda S; Mthethwa N
    Afr J AIDS Res; 2017 Dec; 16(4):335-343. PubMed ID: 29132283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.
    Ardura-Garcia C; Feldacker C; Tweya H; Chaweza T; Kalulu M; Phiri S; Wang D; Weigel R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):e160-7. PubMed ID: 26218409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
    Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
    J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda.
    Abongomera G; Chiwaula L; Revill P; Mabugu T; Tumwesige E; Nkhata M; Cataldo F; van Oosterhout J; Colebunders R; Chan AK; Kityo C; Gilks C; Hakim J; Seeley J; Gibb DM; Ford D
    Int Health; 2018 Jan; 10(1):8-19. PubMed ID: 29329396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.